Author

Jiayi Zhang

Institution: Hua Medicine (China)

Observed institution: Hua Medicine (China)

ORCID: 0000-0001-6002-4846

Observed ORCID: 0000-0001-6002-4846

OpenAlex ID: A5065678258

A phase I open-label clinical trial to study drug-drug interactions of Dorzagliatin and Sitagliptin in patients with type 2 diabetes and obesity

2023 · Li Chen, Jiayi Zhang, et al. · Nature Communications · 27

Population Pharmacokinetic Analysis of Dorzagliatin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus

2023 · Kun Wang, Lingge Feng, et al. · Clinical Pharmacokinetics · 4

A pharmacokinetic and pharmacodynamic drug-drug interaction study of dorzagliatin and empagliflozin in patients with type 2 diabetes and obesity: an open-label phase I trial

2026 · Huan Liu, Yuanhui Zhang, et al. · Nature Communications

Works count: 3

Citation count: 31

H-index: 2

I10-index: 1